SEC Form DEFA14A filed by Phibro Animal Health Corporation

​

​

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

(Amendment No.        )

​

Phibro Animal Health Corporation

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

​

​

​

​

Phibro Animal Health Corporation

Glenpointe Centre East, 3^rd Floor

300 Frank W. Burr Blvd., Ste 21

Teaneck, NJ 07666

​

Important Notice Regarding the Availability of Proxy Materials for the Shareholder Meeting To be held on Tuesday, November 4, 2025

Dear Stockholder:

You are receiving this notice to inform you that the proxy materials for our 2025 Annual Meeting of Stockholders are available on the internet. In accordance with rules adopted by the U.S. Securities and Exchange Commission, we are using the internet as our primary means of furnishing proxy materials to our stockholders. This communication presents only an overview of the more complete proxy materials that are available to you on the internet. We encourage you to access and review all of the important information contained in the proxy materials before voting.

The proxy statement and annual report to stockholders are available at: http://www.astproxyportal.com/ast/18918/. If you want to receive a paper or e-mail copy of these documents, you must request one by sending an e-mail to [email protected] or by calling +1 (201) 329-7331. You will have the opportunity to make a request to receive paper copies for all future meetings or only for the 2025 Annual Meeting of Stockholders. There is no charge to you for requesting a copy. Please make your request for a copy on or before October 20, 2025 to facilitate timely delivery. We encourage you to access and review all of the important information contained in the proxy materials before voting.

The 2025 Annual Meeting of Stockholders (the “Annual Meeting”) of Phibro Animal Health Corporation (the “Company”) will be held at 9:00 A.M. Eastern Time on Tuesday, November 4, 2025, at the Company’s offices located at Glenpointe Centre East, 3rd Floor, 300 Frank W. Burr Blvd., Suite 21, Teaneck NJ 07666. Only holders who owned shares of the Company’s Class A common stock and Class B common stock as of the close of business on September 12, 2025 (the “Record Date”), may vote at the Annual Meeting or any adjournment or postponement of the Annual Meeting that may take place.

Proposals to be voted on at the Annual Meeting are listed below along with the Board of Directors recommendations:

The Board of Directors recommends that you vote FOR this proposal.

The Board of Directors recommends that you vote FOR this proposal.

The Board of Directors recommends that you vote, on an advisory basis, for holding future stockholder advisory votes on the compensation of our named executive officers every 3 YEARS.

The Board of Directors recommends that you vote FOR this proposal.

You may access the following proxy materials at http://www.astproxyportal.com/ast/18918/:

If you are a stockholder of record, there are two ways to vote:

​

Stockholders of record as of the Record Date are encouraged and cordially invited to attend the 2025 Annual Meeting of Stockholders. Stockholders may request directions to the Company’s offices in order to attend the Annual Meeting by calling +1 (201) 329-7331.

​